Tinnitus vs Hearing Loss: Key Differences, Shared Causes, and When to See an Audiologist
Tinnitus and hearing loss are different auditory conditions with overlapping origins — tinnitus is the perception of sound (ringing, buzzing, hissing) when no external source exists, while hearing loss is a measurable reduction in the ability to detect real external sounds. They are frequently confused because they so often co-occur: approximately 80–90% of people with chronic tinnitus have at least some measurable audiometric hearing loss, and cochlear damage from noise and aging generates both simultaneously. Understanding the distinction between tinnitus vs hearing loss is clinically important because they require different diagnostic tests, respond to different interventions, and carry different red flags for serious underlying pathology.
This guide covers the full differential: what each condition actually is, how they overlap, what tests distinguish them, when professional evaluation is urgent, and how nutritional support fits into the picture.
TL;DR
- Tinnitus = phantom sound perception (ringing, buzzing, hissing) with no external source; hearing loss = reduced ability to detect real sounds, measured in decibels on an audiogram.
- About 80–90% of people with chronic tinnitus also have measurable hearing loss — typically sensorineural from the same cochlear hair cell damage.
- Hearing loss commonly causes or worsens tinnitus by reducing peripheral input, triggering the brain to increase its own auditory gain (central sensitization).
- Different tests: pure-tone audiometry quantifies hearing loss; tinnitus pitch matching and masking tests characterize tinnitus separately.
- Red flags requiring urgent ENT/audiologist referral: unilateral tinnitus, pulsatile tinnitus, sudden hearing loss, tinnitus with vertigo or facial weakness.
- For the full causal picture of tinnitus, see what causes tinnitus.
What Is Tinnitus?
Tinnitus is the perception of sound — ringing, buzzing, hissing, clicking, roaring, or whistling — in the absence of an external acoustic source. The word derives from the Latin tinnire (“to ring”). It is not a disease itself but a symptom: an auditory percept generated internally by the auditory nervous system rather than by sound waves entering the ear.
Prevalence: Bhatt JM, Lin HW, Bhattacharyya N. “Prevalence, Severity, Exposures, and Treatment Patterns of Tinnitus in the United States.” JAMA Otolaryngol Head Neck Surg. 2016 Oct 1;142(10):959–965. PMID: 27441392 estimated that approximately 14.3% of American adults report some tinnitus — roughly 35 million people. Of these, approximately 20% describe their tinnitus as bothersome enough to meaningfully affect daily life.
Types of tinnitus:
- Subjective tinnitus — by far the most common type. Only the patient can hear the sound. Generated by abnormal activity in the auditory cortex and central auditory pathways, typically as a consequence of cochlear damage. This is the tinnitus most people mean when they say “my ears are ringing.”
- Objective tinnitus — rare. Produced by a real physical sound source within the body (vascular turbulence, muscular spasms, Eustachian tube dysfunction) that an examiner can sometimes hear with a stethoscope. Pulsatile tinnitus that synchronizes with the heartbeat is usually objective in origin.
- Acute vs chronic — tinnitus lasting fewer than three months is considered acute (often self-resolving after noise exposure); chronic tinnitus persists beyond three months and is far more resistant to resolution.
The neurological basis of chronic subjective tinnitus is well-established: cochlear hair cell loss reduces the auditory input reaching the brainstem and cortex. In response, the brain compensates by increasing its internal amplification — a process called central gain enhancement. The result is that spontaneous neural firing in auditory circuits becomes perceptible as a phantom sound. Roberts LE, Eggermont JJ, Caspary DM, Shore SE, Melcher JR, Kaltenbach JA. “Ringing Ears: The Neuroscience of Tinnitus.” J Neurosci. 2010 Nov 10;30(45):14972–14979. PMID: 21068300 provides an authoritative review of these central mechanisms. The implications of this model — that tinnitus is partly a brain adaptation, not just a cochlear problem — are explored further in our how tinnitus supplements work guide.
What Is Hearing Loss?
Hearing loss is a reduction in the ability to detect sound, measured audiometrically in decibels hearing level (dBHL) across frequencies. The World Health Organization defines disabling hearing loss as hearing loss greater than 35 dB in the better ear. The GBD 2019 Hearing Loss Collaborators (Lancet, 2021, PMID: 33714390) estimated 1.57 billion people globally live with hearing loss, making it the fourth leading cause of years lived with disability worldwide.
Types of hearing loss:
| Type | Location of damage | Common causes | Key characteristic |
|---|---|---|---|
| Sensorineural | Inner ear (cochlear hair cells) or auditory nerve | Noise, aging (presbycusis), ototoxic drugs, genetic | Usually permanent; cochlear hair cells don’t regenerate |
| Conductive | Outer or middle ear (ear canal, eardrum, ossicles) | Earwax, middle ear infection, otosclerosis, perforation | Often reversible or surgically correctable |
| Mixed | Both sensorineural and conductive components | Combined pathology | Requires treatment addressing both components |
Sensorineural hearing loss (SNHL) is by far the most common type and the one most relevant to tinnitus. The cochlea contains approximately 15,000–16,000 outer hair cells that amplify and tune incoming sound; these cells are mechanically delicate and metabolically vulnerable. They do not regenerate in humans. Once destroyed by acoustic trauma, ototoxic drugs, or the cumulative metabolic damage of aging (presbycusis), the resulting threshold shift is generally permanent.
The NIH National Institute on Deafness and Other Communication Disorders reports that approximately 15% of American adults (37.5 million people) have some degree of trouble hearing. Age-related hearing loss affects roughly one-third of adults between 65 and 74 and nearly half of adults over 75.
Tinnitus vs Hearing Loss: Key Differences
| Feature | Tinnitus | Hearing Loss |
|---|---|---|
| Definition | Perception of phantom sound | Reduced detection of real external sound |
| Primary source | Central auditory circuit hyperactivity | Cochlear or auditory pathway damage |
| Measured by | Tinnitus pitch/loudness matching, masking tests | Pure-tone audiogram (dBHL thresholds) |
| Audibility to others | No (subjective) — rarely yes (objective) | Not applicable |
| Common character | Ringing, buzzing, hissing, clicking | Muffled sound, difficulty with speech in noise |
| Reversibility | Acute: often resolves; Chronic: rarely | Conductive: often reversible; SNHL: usually permanent |
| Primary red flag | Unilateral, pulsatile, with vertigo | Sudden onset, asymmetric, progressive |
How Tinnitus and Hearing Loss Co-Occur
The clinical observation that tinnitus and hearing loss so frequently accompany each other is not coincidental — they share a common origin in cochlear hair cell damage.
When outer hair cells die, the auditory nerve fibers that connected to those hair cells lose their primary input. Spontaneous firing rates in those nerve fibers drop; then the auditory brainstem and cortex, detecting a loss of input, compensate by increasing gain — amplifying whatever residual signals remain. This compensatory gain elevation generates the phantom sound experienced as tinnitus.
This model explains a puzzling phenomenon: Schaette R, McAlpine D. “Tinnitus with a Normal Audiogram: Physiological Evidence for Hidden Hearing Loss and Computational Model.” J Neurosci. 2011 Sep 21;31(38):13452–13457. PMID: 21940438 demonstrated that some people with tinnitus but apparently normal audiograms show physiological evidence of hidden hearing loss — specifically, damage to the synaptic connections between hair cells and auditory nerve fibers that conventional audiometry misses. Standard audiograms test thresholds at a quiet baseline; they don’t capture synaptopathy (cochlear synapse loss) that appears at suprathreshold levels and in noise. This hidden hearing loss appears to be sufficient to trigger central gain changes and tinnitus.
The practical implication: normal audiogram results do not rule out cochlear damage or a cochlear contribution to tinnitus. Audiologists increasingly use extended-frequency audiometry (testing up to 16,000 Hz) and auditory brainstem response testing to identify high-frequency or synaptopathic hearing loss that standard 8,000 Hz audiograms miss.
Common Causes of Both Conditions
Most causes of sensorineural hearing loss are also major causes of tinnitus because both flow from cochlear hair cell damage:
Noise-induced damage — the leading preventable cause of both. Single-event acoustic trauma (explosion, gunshot, concert) or cumulative occupational or recreational noise exposure destroys hair cells in a characteristic pattern beginning at the 4,000 Hz region. Noise-induced hearing loss and noise-induced tinnitus often begin simultaneously and progress together. Our what causes tinnitus guide covers the noise mechanism in detail.
Age-related degeneration (presbycusis / age-related tinnitus) — progressive sensorineural hearing loss beginning in the high frequencies is essentially universal with aging. Hair cell loss from accumulated oxidative stress, metabolic changes, and genetic factors produces the characteristic high-frequency notch on audiometry and, in many older adults, concurrent tinnitus. The NIH NIDCD estimates that approximately 90% of people with tinnitus have some degree of sensorineural hearing loss — most commonly age-related.
Ototoxic medications — cisplatin, aminoglycoside antibiotics, high-dose loop diuretics, and very high doses of aspirin or quinine can damage cochlear hair cells. Many cause both threshold shifts and tinnitus as concurrent toxicity effects. Tinnitus preceded by a new medication always warrants a medication review.
Menière’s disease — characterized by the triad of fluctuating sensorineural hearing loss, episodic vertigo, and tinnitus (often low-frequency, roaring). This is one of the conditions where hearing loss, tinnitus, and vestibular symptoms are mechanistically linked through endolymphatic hydrops (excess fluid pressure in the inner ear).
Acoustic neuroma (vestibular schwannoma) — a benign tumor on the vestibulocochlear nerve. The hallmark presentation is unilateral hearing loss and unilateral tinnitus, often with disequilibrium. This diagnosis must be excluded in any patient with asymmetric or unilateral presentations.
Can One Cause the Other?
Hearing loss → Tinnitus: Well-established. The central gain mechanism described above explains how cochlear damage that reduces auditory input generates phantom sound. This directional relationship is supported by the observation that tinnitus onset frequently coincides with or follows documented hearing loss events, and that the pitch of tinnitus typically corresponds to the frequency region of maximum audiometric hearing loss.
Tinnitus → Hearing loss: The reverse is less clear-cut. Tinnitus itself is not known to damage cochlear hair cells. However, some mechanisms warrant noting:
- Acoustic neuroma causes progressive hearing loss independently of and alongside tinnitus — here, a structural lesion causes both, and “the tinnitus causes hearing loss” is a misattribution of the shared cause.
- Chronic tinnitus-related stress may accelerate age-related cochlear changes through elevated cortisol and associated oxidative stress, though this is mechanistically plausible but not well-documented in human longitudinal studies.
- Central auditory processing changes associated with long-standing tinnitus may affect functional hearing even when thresholds remain stable.
The cleaner clinical statement: hearing loss and tinnitus most often co-occur because they share the same etiology, not because one directly causes the other. Exceptions apply for structural lesions.
How Audiologists Diagnose Each Condition
For hearing loss:
- Pure-tone audiometry: The foundational test. Patient responds to tones presented through headphones at standardized frequencies (250–8,000 Hz, sometimes extended to 16,000 Hz) at varying intensity levels. Results plotted on an audiogram as hearing thresholds in each ear. Air conduction and bone conduction testing together identify whether loss is conductive, sensorineural, or mixed.
- Speech audiometry / word recognition testing: Measures how well the auditory system processes speech at suprathreshold levels — critical for characterizing real-world functional impact beyond threshold detection.
- Tympanometry: Assesses middle ear pressure and eardrum mobility — rules out conductive causes (fluid, perforation, ossicular problems).
For tinnitus:
- Tinnitus pitch matching: The audiologist presents tones of varying frequencies and asks the patient to identify which most closely matches the pitch of their tinnitus. Most tinnitus pitches correspond to the region of maximum hearing loss on audiometry, typically 4,000–8,000 Hz for noise-induced cases.
- Minimum masking level testing: Determines how much external sound (in dBSL above threshold) is required to temporarily suppress awareness of the tinnitus. Low minimum masking levels suggest the tinnitus is closer to threshold; higher levels reflect a more intrusive percept.
- Auditory brainstem response (ABR): Electrophysiological test measuring neural response from cochlea to brainstem. Used when acoustic neuroma is suspected or significant inter-ear asymmetry is present.
When to See an Audiologist: Red Flags
Most tinnitus is benign in origin, but certain presentations indicate conditions requiring urgent evaluation:
Unilateral tinnitus — tinnitus in one ear only, particularly if persistent. The most common cause of tinnitus is symmetric cochlear damage (affecting both ears similarly). Asymmetric or unilateral tinnitus raises the probability of a structural lesion — acoustic neuroma being the most important to exclude. MRI with gadolinium contrast of the internal auditory canals is typically indicated.
Pulsatile tinnitus — tinnitus that beats in synchrony with the pulse suggests a vascular source rather than cochlear or central auditory origin. Underlying causes include carotid artery stenosis or atherosclerosis, benign intracranial hypertension (pseudotumor cerebri), arteriovenous fistulas, glomus tumors, and venous sinus stenosis. Vascular imaging (CT angiography or MRI) is warranted.
Sudden sensorineural hearing loss (SSNHL) — acute loss of hearing in one ear over 72 hours or less. SSNHL is a medical emergency with a meaningful recovery rate if treated within the first 24–48 hours (corticosteroids, sometimes hyperbaric oxygen). Do not wait. Any sudden hearing change warrants same-day or next-day ENT evaluation.
Tinnitus with vertigo — the combination of tinnitus and spinning vertigo (not just dizziness) suggests Menière’s disease or other inner ear pathology requiring formal audiological and vestibular evaluation.
Tinnitus with facial weakness — tinnitus combined with ipsilateral facial nerve involvement warrants immediate evaluation for Bell’s palsy, Ramsay Hunt syndrome, or rarely, facial nerve-compressing tumors.
Treatment Approaches
For tinnitus:
No pharmacological treatment has FDA approval specifically for tinnitus. Current evidence-supported approaches include:
- Sound therapy — providing low-level background noise (white noise, nature sounds, notched music) to reduce the contrast between tinnitus and the acoustic environment. Reduces tinnitus salience and habituates the central auditory response.
- Cognitive behavioral therapy (CBT) — the strongest evidence base for reducing tinnitus-related distress. CBT does not eliminate the sound but changes the patient’s cognitive and emotional response to it, reducing functional impairment. Cochrane reviews of tinnitus interventions consistently identify CBT as the most evidence-supported non-invasive approach.
- Tinnitus retraining therapy (TRT) — combines directive counseling (reframing the tinnitus as neutral) with sound therapy. Originally developed by Jastreboff; good observational evidence, less controlled trial data than CBT.
- Hearing aids — for tinnitus patients with concurrent hearing loss, properly fitted hearing aids amplify environmental sound, reducing the perceptual gap that drives central gain elevation. Many modern hearing aids include built-in tinnitus masking features.
For sensorineural hearing loss:
- Hearing aids — the primary evidence-supported intervention for mild to severe SNHL. Amplification restores access to speech and environmental sounds. Modern devices include directional microphones, noise reduction algorithms, and wireless streaming.
- Cochlear implants — for severe to profound SNHL where hearing aids provide insufficient benefit. Bypass the damaged hair cells entirely, electrically stimulating the auditory nerve directly.
- Conductive hearing loss is often surgically or medically correctable: myringotomy for fluid, stapedectomy for otosclerosis, ossicular chain reconstruction for disrupted ossicles.
Nutritional Support: Where Supplements Fit In
For people managing tinnitus, hearing decline, or both, nutritional approaches offer adjunct support — most meaningfully for deficiency correction and cochlear vascular and antioxidant protection. The evidence for supplements is strongest as prevention (during ongoing noise exposure or deficiency) rather than reversal of established damage.
Magnesium has the strongest clinical trial evidence for noise-induced hearing loss prevention, with randomized trials showing significant protection during active noise exposure. The cochlear NMDA receptor-blocking and vascular protection mechanisms are well-characterized. See our magnesium and tinnitus evidence guide for the full clinical trial breakdown.
B vitamins (particularly B12 and folate) support auditory nerve myelination and homocysteine metabolism — elevated homocysteine impairs cochlear microcirculation and is associated with increased tinnitus severity and age-related hearing loss risk. Our B vitamins and hearing guide covers the evidence in detail.
Ginkgo biloba targets cochlear microcirculation through flavonoid antioxidant and platelet-activating factor antagonism. Evidence for tinnitus is mixed, with some trials showing benefit for tinnitus secondary to vascular insufficiency. See our ginkgo biloba for tinnitus review for the full evidence assessment.
Zinc is concentrated in the cochlea and plays a role in auditory nerve function. Deficiency has been associated with tinnitus in some studies, and supplementation trials show modest effects in zinc-deficient tinnitus patients.
Wave-1 hearing support products we review — Audifort, Quietum Plus, Zeneara, ZenCortex, RhythmONE, Sonic Solace, and Echoxen — combine these and related ingredients in multi-component formulas. Our individual reviews assess each formula’s ingredient evidence and dosing against the published clinical literature.
Frequently Asked Questions
What is the difference between tinnitus and hearing loss?
Tinnitus is phantom sound perception — ringing, buzzing, hissing — with no external source, generated by central auditory circuit hyperactivity typically following cochlear damage. Hearing loss is a measurable reduction in the ability to detect real external sounds, quantified in decibels on a pure-tone audiogram. Both frequently co-occur because they share the same cause — cochlear hair cell damage — but they are distinct conditions with different diagnostic tests and treatment approaches.
Can tinnitus cause hearing loss?
Not directly in most cases. Tinnitus itself does not damage hair cells. However, both tinnitus and hearing loss most often arise from the same cochlear pathology, and certain structural causes of tinnitus — particularly acoustic neuroma — do cause progressive hearing loss independently. The central auditory changes accompanying long-standing tinnitus may also affect functional hearing processing without changing measurable thresholds.
Can hearing loss cause tinnitus?
Yes — this is the well-established directional relationship. Cochlear hair cell loss reduces auditory input, and the brain compensates by increasing internal gain. This compensatory amplification of residual auditory signals produces phantom sound. The Schaette and McAlpine (2011) study demonstrated this mechanism even in tinnitus patients with apparently normal audiograms who have hidden synaptic hearing loss detectable physiologically.
What doctor should I see for tinnitus and hearing loss?
Start with your primary care physician for initial evaluation and appropriate referral. An audiologist performs the diagnostic tests — audiograms and tinnitus characterization. An otolaryngologist (ENT) manages medical and surgical causes. Urgent ENT evaluation is necessary for unilateral tinnitus, pulsatile tinnitus, sudden hearing loss, or tinnitus with vertigo.
What tests diagnose tinnitus vs hearing loss?
Hearing loss is primarily diagnosed by pure-tone audiometry. Tinnitus characterization uses pitch matching (identifying the tinnitus frequency) and minimum masking level testing. Tympanometry assesses middle ear function. Auditory brainstem response testing evaluates the neural pathway from cochlea to brainstem and can detect acoustic neuroma or hidden synaptopathy.
Is pulsatile tinnitus more serious than regular tinnitus?
Pulsatile tinnitus — tinnitus that beats with the heartbeat — is more likely to have a vascular or structural cause that requires specific investigation. While most tinnitus is benign in origin, pulsatile tinnitus can indicate carotid artery disease, intracranial hypertension, vascular tumors, or arteriovenous fistulas — some of which are serious and treatable. Prompt vascular imaging evaluation is warranted for pulsatile tinnitus.
Can supplements help with both tinnitus and hearing loss?
Supplements have a clearer role in prevention and deficiency correction than in reversing established damage. Magnesium has strong RCT evidence for reducing noise-induced hearing loss during active noise exposure. B vitamins and zinc support cochlear vascular and nerve function, particularly when deficiency is present. No supplement has been shown to restore hair cells already destroyed. The role of supplements in multi-ingredient formulas is explored in our how tinnitus supplements work guide.
The Bottom Line
Tinnitus and hearing loss are distinct but intimately related auditory conditions. Tinnitus is a phantom sound — a symptom of abnormal central auditory processing. Hearing loss is a measurable deficit in detecting real external sound — a consequence of cochlear or auditory pathway damage. They co-occur in approximately 80–90% of chronic tinnitus cases because cochlear hair cell damage drives both: it reduces external sound detection while simultaneously triggering the central gain compensation that generates phantom sounds.
The differential matters clinically. An audiogram quantifies hearing loss; separate tinnitus characterization tests profile the phantom sound. Hearing loss management centers on amplification and correction of reversible causes; tinnitus management focuses on habituation, sound therapy, and CBT-based distress reduction.
Red flags that warrant urgent evaluation — unilateral tinnitus, pulsatile tinnitus, sudden hearing loss, tinnitus with vertigo — should not be attributed to benign causes without ruling out acoustic neuroma, vascular pathology, and Menière’s disease through appropriate imaging and specialist referral.
For nutritional support within a comprehensive approach, magnesium, B vitamins, zinc, and ginkgo biloba have the strongest mechanistic and clinical rationale. How they fit into the full supplementation picture is covered in our how tinnitus supplements work guide. Our editorial standards and disclosure practices are on our about page and affiliate-disclosure page.
These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. The information in this article is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any supplement program, particularly if you have a diagnosed medical condition, take prescription medications, or are experiencing any of the red-flag symptoms described in this article.